Synbiotics in Infants With Cyanotic Congenital Heart Disease

Efficacy of Synbiotics in Infants With Cyanotic Congenital Heart Disease

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants with CHD. Therefore, the investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Inclusion Criteria:

• Cyanotic congenital heart disease
• infants >35 weeks of gestational age
• Born at or transferred to Sami Ulus CH

Exclusion Criteria:

• Congenital anomalies of the intestinal tract